| Alternative name1 | Anti-TNFRSF1A Polyclonal Antibody |
| Alternative name2 | TNFRSF1A PAb |
| Alternative name3 | TNFRSF1A Polyclonal Antibody |
| Alternative name4 | TNFRSF1A |
| Alternative name5 | N/A |
| Other names | CD_antigen: CD120aCleaved into the following 2 chains:Tumor necrosis factor receptor superfamily member 1A, TBPI, TNF-R1, TNF-R1, TNF-RI, TNF-RI, TNFR-I, TNFR-I, Tumor necrosis factor receptor 1, Tumor necrosis factor receptor superfamily member 1A, Tumor necrosis factor receptor type I, Tumor necrosis factor-binding protein 1, member 1A, membrane form, p55, p60, tumor necrosis factor binding protein 1, tumor necrosis factor receptor 1A isoform beta, tumor necrosis factor receptor superfamily, tumor necrosis factor receptor superfamily member 1A, tumor necrosis factor receptor type 1, tumor necrosis factor-alpha receptor, Tumor necrosis factor receptor superfamily member 1A |
| Gene name | TNFRSF1A |
| Gene name synonims | N/A |
| Other gene names | CD120a, FPF, MS5, TBP1, TBPI, TNF-R, TNF-R-I, TNF-R1, TNF-R55, TNF-RI, TNFAR, TNFAR, TNFR-I, TNFR1, TNFR1, TNFR1-d2, TNFR55, TNFR60, TNFRSF1A, p55, p55-R, p60, TNFRSF1A |
| Category | Antibodies |
| Clonality | Polyclonal |
| Immunoglobulin isotype | IgG |
| Clone | Polyclonal antibody |
| Host organism | Rabbit |
| Species reactivity | Mouse, Rat, Human |
| Specificity and cross-reactivity | N/A |
| Purification method | Affinity Purification |
| Form/Appearance | N/A |
| Concentration | N/A |
| Storage and shipping | Antibodies in liquid form can be shipped and stored for short terms at +4 degrees Celsius, for long term storage (up to one year) 25-50% glycerol or ethylene glycol has to added and the vial must be stored at -20°, C, Lyophilized antibodies may be transported at ambient temperature and stored for short terms at +4 degrees Celsius and at -20 for long term storage |
| Tested for: | Immunohistochemistry (IHC), Western Blot (WB) |
| Description | Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory | For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Group | Polyclonals and antibodies |
| About | The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot |
| Gene target | TNFRSF1A |
| Short name | TNFRSF1A Polyclonal Antibody |
| Technique | Pabs are a collection of immunoglobulin , Polyclonal antibodies , antibodies against human proteins, antibodies for, each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different |
| Alternative name | member 1A polyclonal (Antibody to), tumor necrosis factor receptor superfamily |
| Alternative technique | polyclonals |
| Alternative to gene target | CD120a and FPF and MS5 and p55 and p55-R and p60 and TBP1 and TNF-R and TNF-R-I and TNF-R55 and TNFAR and TNFR1 and TNFR1-d2 and TNFR55 and TNFR60, TNFRSF1A and IDBG-13807 and ENSG00000067182 and 7132, TNFRSF1A and IDBG-640513 and ENSBTAG00000004211 and 282527, Tnfrsf1a and IDBG-189844 and ENSMUSG00000030341 and 21937, member 1A, nuclei, this GO :0000139 and this GO lgi membrane and cellular component this GO :0001666 and response to hypoxia and biological process this GO :0002020 and protease binding and molecular function this GO :0005031 and tumor necrosis factor-activated receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005634 and nucleus and cellular component this GO :0005739 and mitochondrion and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006693 and prostaglandin metabolic process and biological process this GO :0006915 and apoptotic process and biological process this GO :0006952 and defense response and biological process this GO :0006954 and inflammatory response and biological process this GO :0007165 and signal transduction and biological process this GO :0007166 and cell surface receptor signaling pathway and biological process this GO :0008625 and extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :0008630 and intrinsic apoptotic signaling pathway in response to DNA damage and biological process this GO :0009611 and response to wounding and biological process this GO :0009986 and cell surface and cellular component this GO :0010628 and positive regulation of gene expression and biological process this GO :0010629 and negative regulation of gene expression and biological process this GO :0016032 and viral process and biological process this GO :0019221 and cytokine-mediated signaling pathway and biological process this GO :0030424 and axon and cellular component this GO :0032403 and protein complex binding and molecular function this GO :0032496 and response to lipopolysaccharide and biological process this GO :0032715 and negative regulation of interleukin-6 production and biological process this GO :0032760 and positive regulation of tumor necrosis factor production and biological process this GO :0033013 and tetrapyrrole metabolic process and biological process this GO :0033160 and positive regulation of protein import into nucleus, this GO :0002020: protease binding, this GO :0002020: protease binding and also this GO :0005031: tumor necrosis factor-activated receptor activity and also this GO :0005515: protein binding and also this GO :0032403: protein complex binding and also this GO :0043120: tumor necrosis factor binding, this GO :0005031: tumor necrosis factor-activated receptor activity, this GO :0005515: protein binding, this GO :0032403: protein complex binding, this GO :0043120: tumor necrosis factor binding, translocation and biological process this GO :0033209 and tumor necrosis factor-mediated signaling pathway and biological process this GO :0042511 and positive regulation of tyrosine phosphorylation of Stat1 protein and biological process this GO :0042742 and defense response to bacterium and biological process this GO :0042981 and regulation of apoptotic process and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043120 and tumor necrosis factor binding and molecular function this GO :0043123 and positive regulation of I-kappaB kinase/NF-kappaB signaling and biological process this GO :0043200 and response to amino acid and biological process this GO :0043234 and protein complex and cellular component this GO :0043235 and receptor complex and cellular component this GO :0043279 and response to alkaloid and biological process this GO :0043525 and positive regulation of neuron apoptotic process and biological process this GO :0045087 and innate immune response and biological process this GO :0045121 and membrane raft and cellular component this GO :0045202 and synapse and cellular component this GO :0045471 and response to ethanol and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0050728 and negative regulation of inflammatory response and biological process this GO :0050729 and positive regulation of inflammatory response and biological process this GO :0051291 and protein heterooli this GO merization and biological process this GO :0071260 and cellular response to mechanical stimulus and biological process this GO :0071392 and cellular response to estradiol stimulus and biological process this GO :0097190 and apoptotic signaling pathway and biological process, tumor necrosis factor binding, tumor necrosis factor receptor superfamily |
| Identity | 11916 |
| Gene | TNFRSF1A |
| Long gene name | TNF receptor superfamily member 1A |
| Synonyms gene | TNFR1 |
| Synonyms gene name | member 1A , tumor necrosis factor receptor superfamily |
| Synonyms | TNF-R TNFAR TNFR60 TNF-R-I CD120a TNF-R55 |
| Locus | 12p13, 31 |
| Discovery year | 1991-01-15 |
| GenBank acession | M75866 |
| Entrez gene record | 7132 |
| Pubmed identfication | 1655358 2158863 |
| RefSeq identity | NM_001065 |
| Classification | CD molecules Tumor necrosis factor receptor superfamily |
| Havana BLAST/BLAT | OTTHUMG00000168267 |
| Locus Specific Databases | INFEVERS: The repertory of Familial Mediterranean Fever (FMF) and Hereditary Inflammatory Disorders Mutations LRG_193 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue